Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4

Mengshu Wang,1* Yong Zhang,1* Jiao Feng,1 Tiejun Gu,1 Qingguang Dong,1 Xu Yang,2 Yanan Sun,1 Yongge Wu,1 Yan Chen,1 Wei Kong1 1National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun, People’s Republic of China; 2BCHT Biopharm Co, Ltd, Cha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang M, Zhang Y, Feng J, Gu T, Dong Q, Yang X, Sun Y, Wu Y, Chen Y, Kong W
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/44ee12dbf4e04f93a73f232ceb0e850c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:44ee12dbf4e04f93a73f232ceb0e850c
record_format dspace
spelling oai:doaj.org-article:44ee12dbf4e04f93a73f232ceb0e850c2021-12-02T02:44:03ZPreparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-41176-91141178-2013https://doaj.org/article/44ee12dbf4e04f93a73f232ceb0e850c2013-03-01T00:00:00Zhttp://www.dovepress.com/preparation-characterization-and-in-vitro-and-in-vivo-investigation-of-a12482https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Mengshu Wang,1* Yong Zhang,1* Jiao Feng,1 Tiejun Gu,1 Qingguang Dong,1 Xu Yang,2 Yanan Sun,1 Yongge Wu,1 Yan Chen,1 Wei Kong1 1National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun, People’s Republic of China; 2BCHT Biopharm Co, Ltd, Changchun, People’s Republic of China*These authors contributed equally to this workBackground: Exendin-4 is an incretin mimetic agent approved for type 2 diabetes treatment. However, the required frequent injections restrict its clinical application. Here, the potential use of chitosan-coated poly (d,l-lactide-co-glycolide) (CS-PLGA) nanoparticles was investigated for intestinal delivery of exendin-4.Methods and results: Nanoparticles were prepared using a modified water–oil–water (w/o/w) emulsion solvent-evaporation method, followed by coating with chitosan. The physical properties, particle size, and cell toxicity of the nanoparticles were examined. The cellular uptake mechanism and transmembrane permeability were performed in Madin-Darby canine kidney-cell monolayers. Furthermore, in vivo intraduodenal administration of exendin-4-loaded nanoparticles was carried out in rats. The PLGA nanoparticle coating with chitosan led to a significant change in zeta potential, from negative to positive, accompanied by an increase in particle size of ~30 nm. Increases in both the molecular weight and degree of deacetylation of chitosan resulted in an observable increase in zeta potential but no apparent change in the particle size of ~300 nm. Both unmodified PLGA and chitosan-coated nanoparticles showed only slight cytotoxicity. Use of different temperatures and energy depletion suggested that the cellular uptake of both types of nanoparticles was energy-dependent. Further investigation revealed that the uptake of PLGA nanoparticles occurred via caveolin-mediated endocytosis and that of CS-PLGA nanoparticles involved both macropinocytosis and clathrin-mediated endocytosis, as evidenced by using endocytic inhibitors. However, under all conditions, CS-PLGA nanoparticles showed a greater potential to be transported into cells, as shown by flow cytometry and confocal microscopy. Transmembrane permeability analysis showed that unmodified and modified PLGA nanoparticles could improve the transport of exendin-4 by up to 8.9- and 16.5-fold, respectively, consistent with the evaluation in rats.Conclusion: The chitosan-coated nanoparticles have a higher transport potential over both free drug and unmodified particles, providing support for their potential development as a candidate oral delivery agent for exendin-4.Keywords: chitosan, PLGA, intestinal absorptionWang MZhang YFeng JGu TDong QYang XSun YWu YChen YKong WDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2013, Iss default, Pp 1141-1154 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Wang M
Zhang Y
Feng J
Gu T
Dong Q
Yang X
Sun Y
Wu Y
Chen Y
Kong W
Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4
description Mengshu Wang,1* Yong Zhang,1* Jiao Feng,1 Tiejun Gu,1 Qingguang Dong,1 Xu Yang,2 Yanan Sun,1 Yongge Wu,1 Yan Chen,1 Wei Kong1 1National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun, People’s Republic of China; 2BCHT Biopharm Co, Ltd, Changchun, People’s Republic of China*These authors contributed equally to this workBackground: Exendin-4 is an incretin mimetic agent approved for type 2 diabetes treatment. However, the required frequent injections restrict its clinical application. Here, the potential use of chitosan-coated poly (d,l-lactide-co-glycolide) (CS-PLGA) nanoparticles was investigated for intestinal delivery of exendin-4.Methods and results: Nanoparticles were prepared using a modified water–oil–water (w/o/w) emulsion solvent-evaporation method, followed by coating with chitosan. The physical properties, particle size, and cell toxicity of the nanoparticles were examined. The cellular uptake mechanism and transmembrane permeability were performed in Madin-Darby canine kidney-cell monolayers. Furthermore, in vivo intraduodenal administration of exendin-4-loaded nanoparticles was carried out in rats. The PLGA nanoparticle coating with chitosan led to a significant change in zeta potential, from negative to positive, accompanied by an increase in particle size of ~30 nm. Increases in both the molecular weight and degree of deacetylation of chitosan resulted in an observable increase in zeta potential but no apparent change in the particle size of ~300 nm. Both unmodified PLGA and chitosan-coated nanoparticles showed only slight cytotoxicity. Use of different temperatures and energy depletion suggested that the cellular uptake of both types of nanoparticles was energy-dependent. Further investigation revealed that the uptake of PLGA nanoparticles occurred via caveolin-mediated endocytosis and that of CS-PLGA nanoparticles involved both macropinocytosis and clathrin-mediated endocytosis, as evidenced by using endocytic inhibitors. However, under all conditions, CS-PLGA nanoparticles showed a greater potential to be transported into cells, as shown by flow cytometry and confocal microscopy. Transmembrane permeability analysis showed that unmodified and modified PLGA nanoparticles could improve the transport of exendin-4 by up to 8.9- and 16.5-fold, respectively, consistent with the evaluation in rats.Conclusion: The chitosan-coated nanoparticles have a higher transport potential over both free drug and unmodified particles, providing support for their potential development as a candidate oral delivery agent for exendin-4.Keywords: chitosan, PLGA, intestinal absorption
format article
author Wang M
Zhang Y
Feng J
Gu T
Dong Q
Yang X
Sun Y
Wu Y
Chen Y
Kong W
author_facet Wang M
Zhang Y
Feng J
Gu T
Dong Q
Yang X
Sun Y
Wu Y
Chen Y
Kong W
author_sort Wang M
title Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4
title_short Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4
title_full Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4
title_fullStr Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4
title_full_unstemmed Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4
title_sort preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/44ee12dbf4e04f93a73f232ceb0e850c
work_keys_str_mv AT wangm preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
AT zhangy preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
AT fengj preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
AT gut preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
AT dongq preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
AT yangx preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
AT suny preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
AT wuy preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
AT cheny preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
AT kongw preparationcharacterizationandinvitroandinvivoinvestigationofchitosancoatedpolydllactidecoglycolidenanoparticlesforintestinaldeliveryofexendin4
_version_ 1718402157339738112